Kumar, S., Singh, S. K., Viswakarma, N., Sondarva, G., Nair, R. S., Sethupathi, P., . . . Rana, A. (2020). Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8(+) T cells. J Immunother Cancer.
シカゴスタイル引用形Kumar, Sandeep, et al. "Rationalized Inhibition of Mixed Lineage Kinase 3 and CD70 Enhances Life Span and Antitumor Efficacy of CD8(+) T Cells." J Immunother Cancer 2020.
MLA引用形式Kumar, Sandeep, et al. "Rationalized Inhibition of Mixed Lineage Kinase 3 and CD70 Enhances Life Span and Antitumor Efficacy of CD8(+) T Cells." J Immunother Cancer 2020.
警告: この引用は必ずしも正確ではありません.